Mallinckrodt to pay $15M to resolve whistleblower allegations. Exposing Misconduct.

Mallinckrodt to pay $15M to resolve whistleblower allegations

September 9, 2019

Mallinckrodt has agreed to pay $15.4 million to resolve whistleblower allegations that the drugmaker paid physicians illegal kickbacks to boost prescriptions of its pricey H.P. Acthar Gel, the U.S. Justice Department said.

The alleged misconduct was by 12 sales representatives from Questcor Pharmaceuticals, which Mallincrodt acquired in August 2014.

Prosecutors claim that the drugmaker, between 2009 and 2013, “wined and dined” physicians in order to improve Medicare prescription rates and boost profits. The alleged acts, which resulted in false claims being submitted to Medicare, are a violation of the federal Anti-Kickback Statute and the False Claims Act.

Read more here.
The materials on this website are for general information purposes only and should not be construed as legal advice, legal opinion or any other advice on any specific facts or circumstances. Readers should not act or refrain from acting upon this information without seeking professional advice. Transmission of information on or by use of this website is not intended to create, and receipt does not constitute, a lawyer-client relationship between the sender and receiver.
Mobile Menu